Shiri Levy1,2, Hannele Ruohola-Baker1,2

  • 1Institute for Stem Cell and Regenerative Medicine, University of Washington, School of Medicine, Seattle, WA 98109, USA.

Clinical research in oncology
|December 1, 2023
PubMed
概括

研究人员开发了EBdCas9,这是一种精确控制H3K27me3.3等表观遗传标记的工具. 这种表观基因控制使基因调节成为可能,影响细胞周期和发育.